Protirelin is no longer widely used in routine thyroid function testing. Researchers once used this peptide to stimulate thyroid-stimulating hormone (TSH) release and evaluate pituitary response. Before highly sensitive TSH assays became available, the Protirelin stimulation test helped evaluate hypothalamic and pituitary disorders, including central hypothyroidism. It also provided a structured way to study thyroid regulation and endocrine signaling.
However, highly sensitive TSH assays and free thyroid hormone measurements changed thyroid testing. These modern thyroid function tests detect subtle hormone changes through simple blood tests. As laboratory testing improved, Protirelin stimulation testing was gradually replaced by faster and more reliable methods.
Today, Protirelin is used mainly in specialized endocrine research and selected endocrine diagnostic settings, while modern thyroid function tests guide most thyroid evaluations.
Explore Protirelin from Peptide Works, a TRH analog studied for stimulating pituitary response and supporting thyroid function testing research.
How Sensitive TSH Assays Replaced Protirelin in Thyroid Function Tests?

Sensitive TSH assays replaced Protirelin because they detect thyroid dysfunction without stimulation testing. Earlier, researchers used Protirelin to stimulate thyroid-stimulating hormone (TSH) release and evaluate hypothalamic-pituitary-thyroid function. However, improved immunometric assays increased TSH sensitivity by nearly 100-fold during the 1980s making stimulation tests less necessary.
Third-generation TSH assays can measure very low TSH levels and detect thyroid dysfunction earlier. They help identify hyperthyroidism, hypothyroidism, and subclinical thyroid disorders with a simple blood test.
Because basal TSH measurements provide enough diagnostic information in most cases, Protirelin stimulation testing became much less common.
Today, clinical guidelines recommend TSH as the first-line thyroid function test, further reducing the need for Protirelin stimulation testing in routine thyroid evaluation.
Which Thyroid Function Tests Are Now Preferred Over Protirelin?
Modern thyroid function tests measure hormone levels directly instead of using stimulation tests. TSH is the main screening test because even small changes in thyroid hormone levels quickly affect TSH.
If TSH is abnormal, clinicians measure Free T4 to check thyroid hormone levels and evaluate thyroid function. Free T3 testing helps identify hyperthyroidism and may be used when an overactive thyroid is suspected.
Clinicians also use thyroid antibody tests, including thyroid peroxidase and thyroglobulin antibodies. To evaluate autoimmune thyroid disease. Together, these tests provide a more complete evaluation of thyroid function and thyroid disease without requiring Protirelin stimulation testing.
When Is Protirelin Still Used in Thyroid and Endocrine Testing?
Protirelin is now used in specific thyroid function tests when standard hormone measurements remain unclear. The Protirelin stimulation test helps evaluate central hypothyroidism, particularly when Free T4 levels appear low while TSH levels remain normal or low-normal.
This approach supports assessment of the hypothalamic-pituitary-thyroid axis when routine thyroid function tests provide limited insight.
Protirelin testing also helps differentiate central hypothyroidism from primary thyroid dysfunction. Authoritative endocrine reviews note that Protirelin can support evaluation of pituitary dysfunction and abnormal TSH secretion.
These targeted thyroid function tests allow deeper assessment of thyroid regulation when standard blood-based testing does not fully explain hormone patterns.
Additional Peptides Involved in Hormone and Thyroid Testing
Researchers have studied several peptides that affect hormone signaling and endocrine function alongside thyroid testing.
- GHRP-2
- GHRP-6
These peptides are known for their effects on growth hormone pathways and have also been investigated in endocrine research and hormone testing.
GHRP-2 and Its Role in Hormone and Thyroid Testing

GHRP-2 is a synthetic growth hormone-releasing peptide that activates the ghrelin or growth hormone secretagogue receptor, which stimulates growth hormone release from the pituitary gland. Studies show GHRP-2 acts as a potent growth hormone secretagogue and influences endocrine signaling pathways.
Studies also show that GHRP-2 stimulates the release of ACTH and prolactin and increases cortisol levels. These effects show that it influences more than growth hormone release. This multi-hormone response made GHRP-2 useful for evaluating hypothalamic-pituitary function.
More recent studies report that GHRP-2 testing can assess growth hormone secretion and hypothalamic-pituitary axis activity. This made it useful in endocrine testing when a more detailed evaluation of hormone function was needed.
Discover GHRP-2 at Peptide Works, a growth hormone-releasing peptide studied for activating pituitary signaling and endocrine function pathways.
How Does GHRP-6 Interact With Thyroid and Pituitary Function?

GHRP-6 is a synthetic growth hormone-releasing peptide that stimulates the pituitary gland by activating growth hormone secretagogue receptors. This activation increases growth hormone secretion and influences hypothalamic-pituitary signaling.
Studies show GHRP-6 also stimulates ACTH and prolactin release, which indicates broader pituitary hormone activation and endocrine regulation.
Thyroid hormone status can change this response. Studies show that changes in thyroid function affect growth hormone release after GHRP-6 stimulation. This shows that thyroid hormone status influences how the pituitary responds to GHRP-6 during endocrine testing.
These findings show that GHRP-6 is useful for studying growth hormone secretion and hypothalamic-pituitary function. They also show that thyroid hormone status can influence the endocrine response to GHRP-6.
Check out GHRP-6 from Peptide Works, a peptide studied for stimulating growth hormone release and supporting pituitary and hormone signaling research.
The Future of Peptide-Based Thyroid Function Testing
Thyroid function tests now depend on accurate hormone measurements. However, peptides such as Protirelin, GHRP-2 and GHRP-6 have helped researchers better understand pituitary function and hormone signaling.
Studies show these peptides can provide additional information about hypothalamic-pituitary-thyroid axis function in specific endocrine settings.
As endocrine research continues, peptide-based testing may help improve the understanding of hormone regulation and support new testing methods.
At Peptide Works, we provide research peptides for laboratory research, supporting ongoing studies of endocrine function and peptide-based hormone testing.
All products discussed are supplied for research purposes only and are not intended for human use.
References
(1) Kirkegaard C, Norlem N, Lauridsen UB, Bjorum N, Christiansen C. Protirelin stimulation test and thyroid function during treatment of depression. Arch Gen Psychiatry. 1975 Sep;32(9):1115-8.
(2) De Los Santos ET, Mazzaferri EL. Sensitive thyroid-stimulating hormone assays: clinical applications and limitations. Compr Ther. 1988 Sep;14(9):26-33.
(3) Chen LM, Chen YC, Hsiao HP, Chen BH, Chao MC. Role of thyrotropin-releasing hormone test in re-evaluation of congenital hypothyroidism. Kaohsiung J Med Sci. 2014 Aug;30(8):383-9.
(4) Van den Berghe G, Baxter RC, Weekers F, Wouters P, Bowers CY, Iranmanesh A, Veldhuis JD, Bouillon R. The combined administration of GH-releasing peptide-2 (GHRP-2), TRH and GnRH to men with prolonged critical illness evokes superior endocrine and metabolic effects compared to treatment with GHRP-2 alone. Clin Endocrinol (Oxf). 2002 May;56(5):655-69.







